- Point-of-care diagnostics are essential tools used for quick and accurate medical testing at or near the site of patient care, enabling immediate results for conditions such as diabetes, cardiovascular diseases, and infectious diseases
- The demand for point-of-care diagnostics is significantly driven by the increasing prevalence of chronic diseases, advancements in diagnostic technology, and the need for quicker healthcare responses
- U.S. is expected to dominate the North America point-of-care diagnostics market with largest market share of 45.6%, due to the presence of key players such as Abbott, BIOMERIEUX, BD, Siemens Healthineers AG, QIAGEN, Quidel Corporation, and Quest Diagnostics is positively influencing the market growth
- Canada is expected to be the fastest growing country in the North America point-of-care diagnostics market during the forecast period due to country’s aging population, with projections indicating that by 2036, one-fifth of Canadians will be over the age of 65. This demographic shift leads to a higher prevalence of chronic conditions, creating a greater demand for efficient and accessible diagnostic solutions
- Hospitals segment is expected to dominate the market with a largest market share of 37.69% due to the increasing demand for rapid, on-site diagnostic testing in hospital settings, which facilitates timely decision-making and enhances patient care. The integration of miniaturized and wireless POC devices within hospitals allows for efficient bedside testing, reducing the need for centralized laboratory services and expediting the diagnostic process
